Inhibitors of ferroptosis (e.g., DFX and Fer-1) were able to rescue Rb-knockdown HCC cells from cytotoxic effects of sorafenib, suggesting the roles of ferroptosis in sensitizing Rb-knockdown cells to sorafenib treatment. This evidence concerns the gene RB1 and hepatocellular carcinoma.